 |
|
Regulatory molecule for tumor formation or suppression identified by Singapore, US researchers
March 18, 2009MicroRNA targets P53 tumor suppresssor gene
One of the small regulatory molecules, named microRNA-125b, is a novel regulator of p53, an important protein that safeguards cells against cancers, Singapore and U.S. scientists report in the March 17, 2009 issue of the journal Genes & Development.
The scientists found that during embryonic development, this microRNA keeps the level of p53 low to avoid excessive cell death.
But, if the DNA is damaged, the microRNA level is reduced to allow an increase in p53, which eliminates damaged cells and thus prevents tumor formation.
The research was conducted with zebrafish.
"Interestingly, this microRNA is elevated in many types of human cancers, suggesting that it may contribute to the formation of tumours by suppressing the p53 protein," said Bing Lim, M.D., Ph.D., lead author and senior group leader at the Genome Institute of Singapore (GIS), a research institute under the Agency for Science, Technology and Research (A*STAR).
"Hence, our findings have important implications in the diagnosis and treatment of cancers," he added. "The significance of this finding, of course, once again emphasizes the relevance and importance of research linking microRNAs to many subspecialties of human medicine, including cancer and regenerative medicine."
Harvard Medical School's Judy Lieberman, M.D., Ph.D., said, "This important study provides an elegant and beautifully worked out example of the role of microRNAs in master-minding how a cell responds to environmental cues and developmental signals.
"The implication of this study is that these small molecules might be mimicked or antagonized as drugs to treat serious diseases for which no effective treatment exists at present," added Dr. Lieberman, senior investigator at the Immune Disease Institute, and Professor of Pediatrics and Director of the Division of AIDS at Harvard. She is not a co-author of the paper.
Professor of Cell Biology at the Harvard Medical School, Frank McKeon, Ph.D., commented, "This is an elegant use of zebrafish models to uncover how a single microRNA can regulate the p53 tumor suppressor gene. The strength of this regulation suggests that we will hear more about the microRNA-125b in specific human cancers in the near future." Dr. McKeon also is not a co-author of the paper
MicroRNA-125b is a member of the microRNA family of small regulatory molecules that have evolved in nature to regulate tightly the quantity of protein produced by each messenger RNA (mRNA), which generates the group of proteins that determine the unique characteristics of every cell type.
MicroRNAs play complex roles in the simultaneous fine-tuning of many genes in each cell - a role not yet well understood by biologists. It is a complicated, delicate balance that can be profoundly disturbed if just a few microRNAs go awry.
Recent research reveals that microRNAs are abundant in the cell, and that they play important roles in development and in many diseases.
Agency for Science, Technology and Research (A*STAR), Singapore
But, if the DNA is damaged, the microRNA level is reduced to allow an increase in p53, which eliminates damaged cells and thus prevents tumor formation.
The research was conducted with zebrafish.
"Interestingly, this microRNA is elevated in many types of human cancers, suggesting that it may contribute to the formation of tumours by suppressing the p53 protein," said Bing Lim, M.D., Ph.D., lead author and senior group leader at the Genome Institute of Singapore (GIS), a research institute under the Agency for Science, Technology and Research (A*STAR).
"Hence, our findings have important implications in the diagnosis and treatment of cancers," he added. "The significance of this finding, of course, once again emphasizes the relevance and importance of research linking microRNAs to many subspecialties of human medicine, including cancer and regenerative medicine."
Harvard Medical School's Judy Lieberman, M.D., Ph.D., said, "This important study provides an elegant and beautifully worked out example of the role of microRNAs in master-minding how a cell responds to environmental cues and developmental signals.
"The implication of this study is that these small molecules might be mimicked or antagonized as drugs to treat serious diseases for which no effective treatment exists at present," added Dr. Lieberman, senior investigator at the Immune Disease Institute, and Professor of Pediatrics and Director of the Division of AIDS at Harvard. She is not a co-author of the paper.
Professor of Cell Biology at the Harvard Medical School, Frank McKeon, Ph.D., commented, "This is an elegant use of zebrafish models to uncover how a single microRNA can regulate the p53 tumor suppressor gene. The strength of this regulation suggests that we will hear more about the microRNA-125b in specific human cancers in the near future." Dr. McKeon also is not a co-author of the paper
MicroRNA-125b is a member of the microRNA family of small regulatory molecules that have evolved in nature to regulate tightly the quantity of protein produced by each messenger RNA (mRNA), which generates the group of proteins that determine the unique characteristics of every cell type.
MicroRNAs play complex roles in the simultaneous fine-tuning of many genes in each cell - a role not yet well understood by biologists. It is a complicated, delicate balance that can be profoundly disturbed if just a few microRNAs go awry.
Recent research reveals that microRNAs are abundant in the cell, and that they play important roles in development and in many diseases.
Agency for Science, Technology and Research (A*STAR), Singapore
Regulatory Molecule Current Events and Regulatory Molecule News RSSScientists identify genes capable of regulating stem cell function
Scientists from The Forsyth Institute, Boston, MA, and the Howard Hughes Medical Institute at the University of Utah School of Medicine have developed a new system in which to study known mammalian adult stem cell disorders.
Unexpected finding of molecule's dual role in mice may open new avenue to cholesterol reduction
Researchers have discovered an unknown regulator of fat and cholesterol production in the liver of mice, a significant finding that could lead to new therapies for lowering unhealthy blood levels of cholesterol and fats.
Another way to grow blood vessels
Researchers at Dana-Farber Cancer Institute have found a previously unknown molecular pathway in mice that spurs the growth of new blood vessels when body parts are jeopardized by poor circulation.
Study provides hope that some transplant patients could live free of anti-rejection drugs
People with organ transplants, resigned to a lifetime of anti-rejection drugs, may now have reason to hope for a respite, say researchers at Lucile Packard Children's Hospital and the Stanford University School of Medicine.
New angiogenesis finding may help fight cancer growth
A researcher at the University of Wisconsin-Madison School of Medicine and Public Health has discovered a new part of the complicated mechanism that governs the formation of blood vessels, or angiogenesis.
Key root-development pathway mapped using advanced genomic technique
Biologists have vastly expanded understanding of the biological machinery controlling the intricate process by which plant roots burgeon from single cells into complex tissues.
Long-term memory controlled by molecular pathway at synapses
Harvard University biologists have identified a molecular pathway active in neurons that interacts with RNA to regulate the formation of long-term memory in fruit flies.
Tissue stiffness drives tumor formation
The relationship between tissue rigidity and tumor formation is fairly well established; however, what is not so well understood is what happens on a molecular level that contributes to such stiffness.
Scripps Research Scientists Identify the Target of an Immune Suppression Molecule Called CD22-Itself
Scientists at The Scripps Research Institute have applied an innovative approach to studying human proteins that bind to sugar molecules on the surface of human cells to discover how one crucial aspect of our immune system works.
More Regulatory Molecule Current Events and Regulatory Molecule News Articles
|
Human Complement Regulatory Molecules (Molecular Biology Intelligence Unit Series) by B. Paul Morgan (Author) |
| © 2009 BrightSurf.com |